Roberta Dunn

497 total citations
10 papers, 400 citations indexed

About

Roberta Dunn is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roberta Dunn has authored 10 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Roberta Dunn's work include Prostate Cancer Diagnosis and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Roberta Dunn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Roberta Dunn collaborates with scholars based in United Kingdom, United States and Canada. Roberta Dunn's co-authors include David C. Smith, Kenneth J. Pienta, Myla Strawderman, James E. Montie, Marie Sanda, John T. Wei, Robert Marcovich, D L Trump, Ulka N. Vaishampayan and Daniel P. Petrylak and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Roberta Dunn

6 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Dunn United Kingdom	4	332	142	130	72	69	10	400
Ted O. Morgan United States	7	433 1.3×	104 0.7×	272 2.1×	230 3.2×	88 1.3×	10	633
H.K Thakral United States	6	331 1.0×	142 1.0×	53 0.4×	290 4.0×	75 1.1×	10	585
Ahmed Elshafei United States	12	426 1.3×	42 0.3×	150 1.2×	116 1.6×	39 0.6×	49	502
Laurence Bastien France	8	220 0.7×	48 0.3×	83 0.6×	87 1.2×	55 0.8×	13	311
Satoshi Nagamori Japan	12	222 0.7×	73 0.5×	55 0.4×	228 3.2×	72 1.0×	38	424
Hong Hong Huang Singapore	12	220 0.7×	38 0.3×	51 0.4×	111 1.5×	120 1.7×	38	379
C. Surcel Romania	12	279 0.8×	29 0.2×	115 0.9×	89 1.2×	57 0.8×	48	393
Tatsushi Kawada Japan	12	269 0.8×	47 0.3×	28 0.2×	183 2.5×	82 1.2×	64	433
Masaru Hirai Japan	6	282 0.8×	23 0.2×	176 1.4×	67 0.9×	30 0.4×	12	458
E.E. Mullen United States	5	414 1.2×	46 0.3×	37 0.3×	90 1.3×	22 0.3×	6	495

Countries citing papers authored by Roberta Dunn

Since Specialization

Citations

This map shows the geographic impact of Roberta Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Dunn more than expected).

Fields of papers citing papers by Roberta Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Dunn. The network helps show where Roberta Dunn may publish in the future.

Co-authorship network of co-authors of Roberta Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Dunn. A scholar is included among the top collaborators of Roberta Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Dunn. Roberta Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dunn, Roberta, et al.. (2025). Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta‐Analysis of Cardiovascular Safety. eJHaem. 6(1). e70000–e70000.

Smith, Daniel, Andrea Billè, Akshay J. Patel, et al.. (2025). A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA). Clinical Lung Cancer. 26(3). e223–e231. 1 indexed citations

Chehab, Omar, Roberta Dunn, Joshua Wilcox, et al.. (2025). Sex-Related Differences in Patients with Mitral Regurgitation Undergoing Mitral Valve Surgery: A Propensity Score-Matched Study. Journal of Clinical Medicine. 14(9). 3054–3054.

Dunn, Roberta, John Pilling, Karen Harrison‐Phipps, et al.. (2024). Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer. Cancers. 16(17). 3058–3058.

Dunn, Roberta, et al.. (2008). Zur Differentialdiagnose einer hämorrhagischnekrotisierenden Appendix epiploica. DMW - Deutsche Medizinische Wochenschrift. 112(20). 805–806.

Hussain, Mohammad Asif, Daniel P. Petrylak, Roberta Dunn, et al.. (2005). Trastuzumab (T), paclitaxel (P), carboplatin (C), and gemcitabine (G) in advanced HER2-positive urothelial carcinoma: Results of a multi-center phase II NCI trial. Journal of Clinical Oncology. 23(16_suppl). 4507–4507. 24 indexed citations

Wei, John T., Roberta Dunn, Robert Marcovich, James E. Montie, & Marie Sanda. (2000). PROSPECTIVE ASSESSMENT OF PATIENT REPORTED URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 744–748. 193 indexed citations

Sandler, Howard M., Roberta Dunn, John T. Wei, et al.. (2000). Health related quality of life following 3D conformal external beam radiotherapy: treatment factors influence patient-reported outcome. International Journal of Radiation Oncology*Biology*Physics. 48(3). 249–249. 2 indexed citations

Thomas, Chris M.G., Karl R. N. Baumforth, Joanne R. Flavell, et al.. (1999). Absence of prolactin gene expression in colorectal cancer.. Molecular Pathology. 52(3). 135–139. 6 indexed citations

10.

Smith, David C., Roberta Dunn, Myla Strawderman, & Kenneth J. Pienta. (1998). Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.. Journal of Clinical Oncology. 16(5). 1835–1843. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact